SIGNORIELLO, Simona
 Distribuzione geografica
Continente #
EU - Europa 1.018
NA - Nord America 1.016
AS - Asia 220
AF - Africa 3
OC - Oceania 2
SA - Sud America 1
Totale 2.260
Nazione #
US - Stati Uniti d'America 1.014
IE - Irlanda 392
IT - Italia 159
CN - Cina 130
GB - Regno Unito 125
UA - Ucraina 112
DE - Germania 101
SG - Singapore 60
GR - Grecia 34
FI - Finlandia 29
SE - Svezia 21
TR - Turchia 19
FR - Francia 16
BE - Belgio 11
CZ - Repubblica Ceca 8
KR - Corea 7
ES - Italia 5
AT - Austria 2
CA - Canada 2
DZ - Algeria 2
IN - India 2
VN - Vietnam 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
EG - Egitto 1
HU - Ungheria 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
Totale 2.260
Città #
Dublin 387
Chandler 238
Jacksonville 191
Bremen 55
Ann Arbor 54
Princeton 52
Beijing 47
Roxbury 42
Medford 41
Singapore 34
Caserta 33
Woodbridge 22
Boardman 19
Nanjing 18
Wilmington 16
Dearborn 14
Des Moines 14
Mountain View 12
San Mateo 12
Brussels 11
Cambridge 11
Houston 11
Jinan 11
New York 10
Naples 9
Kunming 8
Norwalk 8
Brno 7
Milan 7
Nanchang 7
Los Angeles 6
Seoul 6
Ashburn 5
Munich 5
Napoli 5
Zhengzhou 5
Auburn Hills 4
Düsseldorf 4
Haikou 4
Lappeenranta 4
Ningbo 4
Padova 4
Bologna 3
Menlo Park 3
Piacenza 3
Redwood City 3
Sevilla 3
Taizhou 3
Tianjin 3
Udine 3
Venice 3
Aversa 2
Bergamo 2
Dong Ket 2
Fairfield 2
Guangzhou 2
Lanzhou 2
Segrate 2
Shenyang 2
Albano Laziale 1
Bauru 1
Brdo 1
Cairo 1
Calgary 1
Castel Campagnano 1
Castellana Grotte 1
Castelnovo di Sotto 1
Elora 1
Forlì 1
Formia 1
Frankfurt am Main 1
Fuzhou 1
Gunzenhausen 1
Hangzhou 1
Hebei 1
Hefei 1
Helsinki 1
Kinnerton 1
Kyiv 1
Limbiate 1
London 1
Lowestoft 1
Luino 1
Madrid 1
Mcallen 1
Melbourne 1
Orange 1
Palagiano 1
Palermo 1
Pamplona 1
Pune 1
San Diego 1
San Nicola la Strada 1
Sant'anastasia 1
Sant'angelo D'alife 1
Secaucus 1
Shanghai 1
Simi Valley 1
Stockholm 1
Torino 1
Totale 1.541
Nome #
Effects of sildenafil on the gastrocnemius and cardiac muscles of rats in a model of prolonged moderate exercise training. 98
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 89
Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials 76
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): A randomised, multicentre, open-label, phase 3 trial 76
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial 69
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer 68
Cisplatin in addition to single-agent first-line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC): efficacy results of a joint analysis of the multicentre, randomized phase 3 MILES-3 and MILES-4 studies 63
Epidemiological study on behavioural and emotional problems in developmental age: prevalence in a sample of Italian children, based on parent and teacher reports. 62
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. 59
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa 59
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 53
Early PET/CT Scan Is More Effective Than RECIST in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus Bevacizumab 53
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 51
Blood transfusions and adverse acute events: a retrospective study from 214 transfusion-dependent pediatric patients comparing transfused blood components by apheresis or by whole blood 50
Characterization of canine platelet adhesion to extracellular matrix proteins 49
EPIDEMIOLOGY OF MILD ANEMIA IN NON-DIALYSIS CKD: A PROSPECTIVE COHORT STUDY IN OUTPATIENT RENAL CLINICS 49
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials 49
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study 48
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 48
Time spent for activation of non-profit studies in oncology in Italy 47
A prognostic index for patients within the intermediate stage of hepatocellular carcinoma 47
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 47
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-alpha in advanced malignant melanoma 46
EFFICACY OF CEFTAZIDIME-AVIBACTAM IN MONOTHERAPY OR COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE ORGANISMS: A META-ANALYSIS 46
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study 45
Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer 44
Epidemiological pattern of bullying using a multi-assessment approach: Results from the Bullying and Youth Mental Health Naples Study (BYMHNS) 44
Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials 43
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients. 42
Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections 42
Phase I-II Trial of Gemcitabine-Based First-Line Chemotherapies for Small Cell Lung Cancer in Elderly Patients with Performance Status 0-2 The G-Step Trial 41
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer 39
Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research 39
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials 39
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial 38
Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials 38
From histogram data to model data analysis 37
Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study 36
Specific Association of Teratogen and Toxicant Metals in Hair of Newborns with Congenital Birth Defects or Developmentally Premature Birth in a Cohort of Couples with Documented Parental Exposure to Military Attacks: Observational Study at Al Shifa Hospital, Gaza, Palestine 35
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs 32
Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study 30
Phantom Phone Signals in youths: Prevalence, correlates and relation to psychopathology 29
Quality of life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 28
Modeling for the Stringency of Lock-Down Policies: Effects of Macroeconomic and Healthcare Variables in Response to the COVID-19 Pandemic 26
Endocrine effects of aromatase inhibitors as adjuvant treatment in postmenopausal breast cancer patients 25
Diabetic foot problems during the COVID-19 pandemic in a tertiary care center: The emergency among the emergencies 25
Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients 24
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab 23
Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD 23
Evaluation of angiogenesis-related genes as prognostic biomarkers of bevacizumab treated ovarian cancer patients: Results from the phase iv mito16a/mango ov-2 translational study 23
Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study) 22
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer 21
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 20
No additional benefit of prescribing a very low-protein diet in patients with advanced chronic kidney disease under regular nephrology care: a pragmatic, randomized, controlled trial 15
Adherence to mediterranean diet and the risk of differentiated thyroid cancer in a European cohort: The EPIC study 13
Sex difference in ambulatory blood pressure control associates with risk of ESKD and death in CKD patients receiving stable nephrology care 13
Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis 13
Reply to Mocanu CA et al 8
Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes 5
Risk Factors for the Spread of Brucellosis in Sheep and Goats in the Campania Region in the Years 2015-2020 4
Una ricerca epidemiologica sul bullismo: dati della città metropolitana di Napoli 3
Totale 2.429
Categoria #
all - tutte 10.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.906


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020260 0 35 12 4 30 22 47 17 28 23 36 6
2020/2021309 24 3 31 11 66 9 46 23 18 33 38 7
2021/2022348 17 0 0 7 99 3 11 21 10 53 22 105
2022/2023826 65 22 28 79 93 85 4 41 375 7 13 14
2023/2024258 27 14 12 16 84 17 4 7 3 5 23 46
2024/202516 10 6 0 0 0 0 0 0 0 0 0 0
Totale 2.429